| TANNINS | Maplexins A –I (C13H16O9) | Down-regulation of cyclins A and B1 and upregulating of cyclin E, cell-cycle arrest in S phase, induction of apoptosis via intrinsic pathway (FAS-independent, caspase 8-independent) through bcl-XL down-regulation with mitochondrial release of cytochrome c into the cytosol, activation of initiator caspase 9 and effector caspase-3. | HCT-116, Caco-2, CCD-112CoN | [147] [148] |
Oral Cancer | FLAVONOIDS | Flavanones (C15H10O3) | Interaction with phase I metabolizing enzymes (e.g., cytochrome P450), which metabolically inactivate a large number of procarcinogens. | HSC-2, HSG, SCC-25 | [149] [150] [151] [152] [153] |
Isoflavonone (C15H12O2) | |||||
EGC (C15H14O7) | |||||
Chalcones (C15H12O) | |||||
EGCG (C22H18O11) | |||||
Curcumin (C21H20O6) | |||||
Genistein (C15H10O5) | |||||
Quercetin, (C15H10O7) | |||||
Cisplatin (C20H28N12O9PPt+) | |||||
TANNINS | Total Pomegranate Tannin (TPT) extract | Anti-proliferative activity | KB, CAL27 | [147] | |
Lung Cancer | FLAVONOID | Flavone (C15H10O2) | Inhibition of tyrosine kinases. | SK-LU1, SW900, H441, H661, haGo-K-1, A549 | [154] [155] |
Quercetin (C15H10O7) | |||||
ALKALOID | Vinblastin (C46H58N4O9) | Inhibition of cellular proliferation by altering the dynamics of tubulin addition and loss at the ends of mitotic spindle microtubules. | A549 | [117] [119] [141] [156] [157] | |
Vincristine (C46H56N4O10) | |||||
Taxol (C47H51NO14) | |||||
Camptothecin (C20H16N2O4) |